Vaccine "GC Flu Quadrivalent"

Use of GiC Flu Quadrivalent vaccine

Use of GiC Flu Quadrivalent vaccine


The vaccine should be administered by intramuscular injection.

The recommended intramuscular injection site for children aged 6 to 35 months is the anterolateral thigh (or the deltoid muscle if muscle mass is sufficient), and for children aged 36 months and older the deltoid muscle .

  • What are the indications for the GiC Flu Quadrivalent vaccine?

    Active immunization of adults and children 6 months of age and older to prevent influenza caused by the influenza A virus subtypes and influenza B virus types contained in this vaccine.

  • What are the contraindications to the GiC Flu Quadrivalent vaccine?

    Vaccination with the drug is contraindicated for the following categories of patients:

    • patients with hypersensitivity to vaccine components;
    • patients with hypersensitivity to eggs and chicken protein, another chicken component;
    • patients with fever or insufficient nutrition;
    • patients with chronic kidney or liver failure, acute cardiovascular and respiratory diseases, other infectious diseases;
    • persons who had convulsions within 1 year before vaccination;
    • patients with Guillain-Barré syndrome within 6 weeks after previous influenza vaccination or patients with neurological disorders;
    • persons with immunodeficiency;
    • patients until full recovery or persons in the incubation period of the disease;
    • persons who have had a fever the day before or allergy symptoms, for example, a generalized rash with a previous vaccination.

  • What are the side effects of the GiC Flu Quadrivalent vaccine?

    Possible local reactions, such as:

    • redness;
    • edema;
    • pain;

    Common reactions such as:

    • fever;
    • chills;
    • headache;
    • increased fatigue;
    • vomiting

    Such reactions, as a rule, pass within 2-3 days.

    Rarely, acute disseminated encephalomyelitis may develop.

    Fever, headache, convulsions, dyskinesia, and confusion usually occur within 2 weeks of vaccine administration. If these symptoms are suspected, appropriate treatment is carried out, the diagnosis must be confirmed by MRI or other diagnostic methods.

    Very rarely can be observed:

    • allergic reaction;
    • anaphylactic shock.

    Temporary disorders of the central and peripheral nervous system are rarely possible. Cases were reported:

    • paralysis;
    • neuralgia;
    • cerebral hemorrhage;
    • inflammation of the nervous system (for example, Guillain-Barré syndrome).

Not available

  • Producing country:Korea
  • Composition and form of release:Suspension for injection.

note_alt Sign up for vaccinations